IL82627A0 - Bacteriocins and compositions thereof in anti-viral treatment - Google Patents

Bacteriocins and compositions thereof in anti-viral treatment

Info

Publication number
IL82627A0
IL82627A0 IL82627A IL8262787A IL82627A0 IL 82627 A0 IL82627 A0 IL 82627A0 IL 82627 A IL82627 A IL 82627A IL 8262787 A IL8262787 A IL 8262787A IL 82627 A0 IL82627 A0 IL 82627A0
Authority
IL
Israel
Prior art keywords
bacteriocins
compositions
viral treatment
viral
treatment
Prior art date
Application number
IL82627A
Other languages
English (en)
Original Assignee
Univ Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toronto filed Critical Univ Toronto
Publication of IL82627A0 publication Critical patent/IL82627A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL82627A 1986-05-28 1987-05-22 Bacteriocins and compositions thereof in anti-viral treatment IL82627A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86825086A 1986-05-28 1986-05-28

Publications (1)

Publication Number Publication Date
IL82627A0 true IL82627A0 (en) 1987-11-30

Family

ID=25351316

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82627A IL82627A0 (en) 1986-05-28 1987-05-22 Bacteriocins and compositions thereof in anti-viral treatment

Country Status (8)

Country Link
EP (1) EP0247873A3 (da)
JP (1) JPS6379837A (da)
AU (1) AU7360387A (da)
DK (1) DK273087A (da)
FI (1) FI872363A (da)
IL (1) IL82627A0 (da)
MC (1) MC1822A1 (da)
NO (1) NO872223L (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63290824A (ja) * 1987-05-22 1988-11-28 Sumitomo Chem Co Ltd ウイルス感染症治療剤
IL88480A0 (en) * 1987-11-27 1989-06-30 Univ Toronto Proteinaceous compositions
CN1314806C (zh) * 2005-01-14 2007-05-09 四川大学 小型化抗eb病毒肿瘤多肽及其应用与制备方法
WO2021201699A1 (en) * 2020-04-03 2021-10-07 Blis Technologies Limited Antiviral treatment comprising blis containing probiotic products

Also Published As

Publication number Publication date
JPS6379837A (ja) 1988-04-09
AU7360387A (en) 1987-12-03
NO872223D0 (no) 1987-05-27
FI872363A (fi) 1987-11-29
DK273087A (da) 1987-11-29
FI872363A0 (fi) 1987-05-27
EP0247873A2 (en) 1987-12-02
MC1822A1 (fr) 1988-03-18
DK273087D0 (da) 1987-05-27
NO872223L (no) 1987-11-30
EP0247873A3 (en) 1988-10-19

Similar Documents

Publication Publication Date Title
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
DE3666855D1 (en) Alcalisilicate compositions and their use
IL78934A0 (en) Alfuzosine compositions and use
SG75691G (en) Physiologically active and nutritional composition
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
NZ220365A (en) Antiviral peptides and pharmaceutical compositions
SG56192G (en) Biocidal composition and use thereof
EP0247828A3 (en) Copolyester and compositions comprising it
PH24904A (en) N-substituted-arylalkyl and arylalkylene aminoheterocyclics as antisectory agents
NZ208669A (en) Human calcitonin 2, and pharmaceutical compositions
AR242084A1 (es) Una composicion bactericida.
NZ214702A (en) Using interferon in treatments and pharmaceutical compositions
GB8911294D0 (en) Composition and use
GB2216386B (en) Canning process and composition
GB2235910B (en) Improvements in and relating to conveying
GB8808758D0 (en) Nutritional and medicinal compositions
GR860075B (en) Compositions their preparation and use
GB2215601B (en) Radiation - screening compositions containing elderblossom extracts and use thereof
EP0331588A3 (en) Bleach-accelerating compositions and use thereof in photographic color processing
NZ220770A (en) Benzimidazoles and pharmaceutical compositions
EP0230052A3 (en) Immunoamplifiers and related compositions
IL82627A0 (en) Bacteriocins and compositions thereof in anti-viral treatment
GB2133056B (en) Improvements in and/or relating to cribwalling
NZ218087A (en) 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and pharmaceutical compositions